Please assess the completion status of the following clinical trial:

Trial Title: NSAID Use in Postpartum Hypertensive Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* vaginal delivery~* diagnosis of chronic hypertension, chronic hypertension with superimposed preeclampsia~* preeclampsia without severe features~* preeclampsia with severe features gestational hypertension without severe range blood pressures~* gestational hypertension with severe range blood pressures~* singleton pregnancies~Exclusion Criteria:~* Cesarean Delivery~* no diagnosis of hypertensive disorder~* chronic or acute renal disease~* allergy to ibuprofen or acetaminophen~* lupus~* multiple order pregnancies (twins, triplets)~* Narcotic addiction/ in treatment for substance abuse/ current prescription drug user/ current use of illegal drugs

- Gender: FEMALE
- Minimum Age: 14 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Acetaminophen (Type: OTHER): Patients will be monitored for change in blood pressure
- NSAID (Type: OTHER): Patients will be monitored during their postpartum stay (typical 2 days) and then again at 1 week and 6 weeks (standard practice of care) with blood pressure measurements

Based on this trial design, predict the completion outcome and termination type (if applicable).